Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2012
02/09/2012WO2011044503A9 Antibacterial aminoglycoside analogs
02/09/2012WO2011044498A9 Antibacterial aminoglycoside analogs
02/09/2012US20120036589 Vaccine
02/09/2012US20120035279 Protocol for screening travelers
02/09/2012US20120035264 Use of methionine sulfoximine to treat acute liver failure and other diseases caused by an inflammatory cytokine response
02/09/2012US20120035255 Derivative of [(3-hydroxy-4 pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs
02/09/2012US20120035253 Crystalline forms of genistein
02/09/2012US20120035240 Conserved hbv and hcv sequences useful for gene silencing
02/09/2012US20120035233 Medicinal cream made using miconazole nitrate and chitosan and a process to make the same
02/09/2012US20120035226 Oxadiazole derivatives
02/09/2012US20120035219 Compound for the Treatment of Tuberculosis
02/09/2012US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
02/09/2012US20120035209 Hydroxy Substituted 1H-Imidazopyridines and Methods
02/09/2012US20120035208 Pyrazolopyridine pi3k inhibitor compounds and methods of use
02/09/2012US20120035206 Preparation and application of novel antibacterial and anticancer compounds and their derivatives
02/09/2012US20120035198 Antiviral Compounds and Methods of Using Thereof
02/09/2012US20120035194 Substituted 2-amino-fused heterocyclic compounds
02/09/2012US20120035186 Composition comprising azole fungicide and water soluble metal salt
02/09/2012US20120035175 Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/09/2012US20120035168 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
02/09/2012US20120035166 Methods of treating a pulmonary bacterial infection using fluoroquinolones
02/09/2012US20120035154 Modulators of Cellular Adhesion
02/09/2012US20120035150 Mif inhibitors and their uses
02/09/2012US20120035144 Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it.
02/09/2012US20120035142 Polymorphs of darunavir
02/09/2012US20120035136 Antisense antiviral compounds and methods for treating a filovirus infection
02/09/2012US20120035125 Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections
02/09/2012US20120035124 Use of nifuratel to treat infections caused by atopobium species
02/09/2012US20120035121 Antibiotic product, use and formulation thereof
02/09/2012US20120035115 Chemical modifications of monomers and oligonucleotides with cycloaddition
02/09/2012US20120035098 Novel antiviral agent
02/09/2012US20120035097 Methods of treating bacterial infections using oritavancin
02/09/2012US20120034689 Mycobacterial antigens expressed during latency
02/09/2012US20120034325 Formulation for Prevention and Treatment of Bacterial Infections and Preparation Thereof
02/09/2012US20120034321 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
02/09/2012US20120034320 Skin Penetration Composition
02/09/2012US20120034319 Antimicrobial hydrochloric acid catheter lock solution and method of use
02/09/2012US20120034316 Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues
02/09/2012US20120034311 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
02/09/2012US20120034298 Chewable Soft Capsule
02/09/2012US20120034271 Injectable in-situ crosslinked hydrogel and methods of making and using thereof
02/09/2012US20120034270 S1P Receptors Modulators
02/09/2012US20120034268 Bacterial ghosts for mediating innate immunity
02/09/2012US20120034267 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof
02/09/2012US20120034266 Methods and compositions for improving immune response by a nutraceutical antioxidant
02/09/2012US20120034265 Influenza hemagglutinin and neuraminidase variants
02/09/2012US20120034263 Sequences diagnostic for shrimp pathogens
02/09/2012US20120034262 Bovine Herpes Virus-1 Compositions, Vaccines and Methods
02/09/2012US20120034261 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2012US20120034259 Antigen delivery vectors and constructs
02/09/2012US20120034257 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
02/09/2012US20120034256 Hcv vaccines and methods for using the same
02/09/2012US20120034255 Conformationally stabilized hiv envelope immunogens
02/09/2012US20120034254 Antigenic cloaking and its use
02/09/2012US20120034253 Influenza Vaccines, Antigens, Compositions, and Methods
02/09/2012US20120034249 Methods for Treating Progressive Multifocal Leukoencephalopathy (PML)
02/09/2012US20120034239 Proteins with improved solubility and methods for producing and using same
02/09/2012US20120034238 Compositions and methods for treating hepatitis virus infection
02/09/2012US20120034232 Tlr3 binding agents
02/09/2012US20120034230 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA
02/09/2012US20120034220 Mucin Fusion Polypeptide Vaccines, Compositions And Methods Of Use Thereof
02/09/2012US20120034216 Spiroketals
02/09/2012US20120034209 Treatment
02/09/2012US20120034197 Hiv-resistant stem cells and uses thereof
02/09/2012US20120034189 Means and methods for durable inhibition of pathogens
02/09/2012US20120034187 Hepatitis C Inhibitor Compounds
02/09/2012US20120034184 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication
02/09/2012US20120034176 Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof
02/09/2012US20120034169 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
02/09/2012US20120034160 Dual variable domain immunoglobulins and uses thereof
02/09/2012US20120034159 Antibodies that bind both bcma and taci
02/09/2012CA2807589A1 Combinations of hepatitis c virus inhibitors
02/09/2012CA2807540A1 Medicinal agent and mode of prevention of hiv contamination, prevention and treatment of diseases caused by hiv and hiv-associated diseases including aids
02/09/2012CA2807529A1 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
02/09/2012CA2807528A1 St-246 liquid formulations and methods
02/09/2012CA2807357A1 Microparticle formulation for pulmonary drug delivery of anti-infective molecule for treatment of infectious diseases
02/09/2012CA2807305A1 Hepatitis c virus inhibitors
02/09/2012CA2807075A1 Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine
02/09/2012CA2806454A1 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof
02/09/2012CA2806185A1 Combination of a pyrroloquinoline compound and an aminoglycodise antimicrobial agent
02/09/2012CA2805440A1 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
02/09/2012CA2805358A1 Compounds with antibacterial activity against clostridium
02/09/2012CA2799516A1 Immunological function enhancing agent
02/08/2012EP2415782A1 Compounds stimulating undesirable cellular adhesion and applications thereof
02/08/2012EP2415781A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
02/08/2012EP2415776A1 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
02/08/2012EP2415486A2 Conjugates and compositions for cellular delivery
02/08/2012EP2415483A1 Single dose use of cd20-specific binding molecules
02/08/2012EP2415477A1 Traditional chinese medicinal ointment for treating burn, scald and infective trauma and preparative method thereof
02/08/2012EP2415473A1 Oral Care Compositions Containing Combinations of Anti-Bacterial and Host-Response Modulating Agents
02/08/2012EP2415462A1 Improved pharmaceutical compositions for poorly soluble drugs
02/08/2012EP2414369A1 Imidazo [2, 1-b][ 1, 3, 4]thiadiazole derivatives
02/08/2012EP2414352A1 Hepatitis c virus inhibitors
02/08/2012EP2414350A1 Hepatitis c virus inhibitors
02/08/2012EP2413975A1 Lipopeptide inhibitors of hiv-1
02/08/2012EP2413974A1 Conjugated antimicrobial agents
02/08/2012EP2413959A1 Compositions comprising chlamydia antigens
02/08/2012EP2413951A2 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies
02/08/2012EP2413950A2 Antigenic peptide of hsv-2 and methods for using same
02/08/2012EP2413928A1 Use of flavonoids to increase the bioavailability of hesperetin
1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 1798